MSU and TMA are leading the first-ever Adult Dermatomyositis Externally-Led Patient-Focused Drug Development (EL-PFDD) meeting on June 7, 2024....
Tag Archive for: clinical trials
Join MSU and TMA for a Community Orientation Webinar to learn how you can participate virtually in the first-ever...
Watch the recording of this great webinar that includes excellent Q&A! Alvaro Silberstein, co-founder of "Wheel the World" joins...
Watch the MINT Clinical Trial for Myositis Patients with Interstitial Lung Disease Webinar
Myositis Support, , Featured, Research, VideoWatch the MINT Clinical Trial for Myositis Patients with Interstitial Lung Disease webinar with Dr. Rohit Aggarwal. This clinical...
Join Dr. Rohit Aggarwal and MSU for a webinar about The MINT Clinical Trial for Myositis Patients with Interstitial...
The VALOR Study for Dermatomyositis by Priovant Therapeutics
Myositis Support, , Dermatomyositis, Featured, VideoPriovant Therapeutics joins MSU to discuss The Valor Study for Dermatomyositis, a phase 3 clinical trial for Adult Dermatomyositis....
The VALOR Study – New Clinical Research Opportunity for Dermatomyositis
Myositis Support, , Dermatomyositis, Featured, VideoWe hosted Priovant Therapeutics to discuss The Valor Study, a phase 3 clinical trial for adult dermatomyositis. Learn all...
Please join us for a webinar about the new VALOR study. The purpose of the VALOR Study is to...
Kezar Announces Topline Results from the PRESIDIO Trial of Zetomipzomib for the Treatment of Dermatomyositis and Polymyositis
Watch the recording with Alexion Pharmaceuticals to learn about the Flex Study to evaluate the safety and efficacy of...
Join MSU with Sanjay Rakhade MD, PhD, Executive Medical Director at Alexion Astra Zeneca Rare Disease Unit to learn...
MSU to host the first FDA Listening Session for Adult Dermatomyositis!
Myositis Support, , Featured, News, ResearchMSU is hosting the first FDA Listening Session on Adult Dermatomyositis on April 26, 2022. We hope the FDA will come...
Corbus Pharmaceuticals Announces Topline Results from DETERMINE Phase 3 Study of Lenabasum for Treatment of Dermatomyositis
Myositis Support, , Dermatomyositis, Featured, ResearchCorbus releases topline results for the phase 3 study of lenabasum in dermatomyositis. While it didn't meet the primary...
Orphazyme announces topline results of Phase 2/3 trial of arimoclomol for Inclusion Body Myositis (IBM)
Myositis Support, , Featured, Inclusion Body Myositis (IBM), NewsLearn more about the announcement from Orphazyme, communicating the topline results from the Phase 2/3 trial of arimoclomol for...
A Closer Look: Clinical Trials and the PRESIDIO Study
Myositis Support, , Dermatomyositis, Featured, Necrotizing Autoimmune Myopathy, Polymyositis, VideoClinical trials are a key research tool for advancing medical knowledge and patient care. Join Kezar Life Sciences as...
Third Annual “A Day of Remembrance” a video event to honor and remember those we have lost with myositis....
Educational and engaging discussion w/ Dr. Andrew Mammen around immune-mediated necrotizing myopathy (IMNM) and the phase 2 clinical trial...
Clinical Trial of Arimoclomol in Inclusion Body Myositis during the COVID-19 Pandemic
Myositis Support, , Featured, Inclusion Body Myositis (IBM), NewsInformation from Orphazyme A/S about the Clinical Development of Arimoclomol in sIBM during the COVID-19 Pandemic. Read a statement...
Introduction to the PRESIDIO Clinical Trial of KZR-616 for the Treatment of Polymyositis and Dermatomyositis
Myositis Support, , Featured, VideoDr. Mary Katherine (MK) Farmer, MD, Rheumatologist and Senior Medical Director at Kezar Life Sciences, joined us live online...